PACIFIC BIOSCIENCES OF CALIFORNIA, INC. cotiza a 2.10 USD y tiene una capitalización bursátil de $653M. En los últimos 12 meses ha facturado $159M con un margen de flujo de caja libre del -71.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for speci…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.14 | $-0.12 | $-0.12 |
| Estimado | $-0.13 | $-0.13 | $-0.13 | $-0.13 |
| Sorpresa | — | -7.7% | +7.7% | +7.7% |
| Métrica | PACB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 28.6% | 57.0% | -28.4% |
| Operating Margin | -346.1% | -38.6% | -307.5% |
| Net Margin | -341.5% | -33.6% | -307.9% |
| FCF Margin | -71.2% | -13.9% | -57.3% |
| ROE | -10214.5% | -40.4% | -10174.1% |
| ROA | -69.7% | -32.0% | -37.7% |
| Current Ratio | 5.15 | 2.84 | +2.31 |
| Debt / Equity | — | 0.28 | — |